New program aims to boost HIV prevention in pregnant women

NCT ID NCT06226155

First seen Feb 06, 2026 · Last updated May 29, 2026 · Updated 12 times

Summary

This study is creating a program called TENDAI4PrEP to help pregnant women in Zimbabwe take PrEP, a daily pill that prevents HIV. The program combines problem-solving skills with support for depression and anxiety. Researchers will test it with 132 pregnant women and their healthcare providers to see if it is practical and well-liked. If successful, the program could be expanded to protect more women and their babies from HIV.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Zimbabwe

    RECRUITING

    Harare, Zimbabwe

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.